Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2012 12:00 ET | Source: Affitech A/S

Notification pursuant to Section 28a of the Danish Securities Trading Act

Copenhagen and Oslo, 2012-09-03 18:00 CEST (GLOBE NEWSWIRE) -- Affitech has today received a major shareholder notification from Trans Nova Investments Ltd., who in accordance with Section 28a of...
September 03, 2012 12:00 ET | Source: Affitech A/S

Meddelelse i henhold til værdipapirhandelslovens § 28a

København og Oslo, 2012-09-03 18:00 CEST (GLOBE NEWSWIRE) -- Affitech har d.d. modtaget storaktionærmeddelelse fra Trans Nova Investments Limited, som i henhold til værdipapirhandelslovens 28a,...
August 31, 2012 03:32 ET | Source: Affitech A/S

Resultat af offentligt købstilbud til alle andre aktionærer i Affitech A/S fremsat af Trans Nova Investments Limited

København, 2012-08-31 09:32 CEST (GLOBE NEWSWIRE) -- På vegne Trans Nova Investments Limited offentligøres hermed meddelelse fra Trans Novas Investments Limiteds om resultatet af Trans Novas...
August 31, 2012 03:32 ET | Source: Affitech A/S

Results of public purchase offer to all other shareholders of Affitech A/S, made by Trans Nova Investments Limited

Copenhagen, Denmark, 2012-08-31 09:32 CEST (GLOBE NEWSWIRE) -- On behalf of Trans Nova Investments Limited, we hereby release announcement received from Trans Nova Investments Limited concerning the...
August 30, 2012 11:41 ET | Source: Affitech A/S

Affitech A/S reports financial result for the first six months of 2012

Copenhagen and Oslo, 30th August, 2012, 2012-08-30 17:41 CEST (GLOBE NEWSWIRE) -- Clinical trials sites initiated in Russia in late June 2012 by Affitech’s collaboration partner IBC Generium for...
August 30, 2012 11:41 ET | Source: Affitech A/S

Affitech A/S rapporterer regnskabsresultat for de første seks måneder af 2012

København og Oslo, 30. august 2012, 2012-08-30 17:41 CEST (GLOBE NEWSWIRE) -- Etablering af kliniske forsøgssteder indledt i Rusland ultimo juni 2012 af Affitechs samarbejdspartner IBC Generium...
August 20, 2012 02:33 ET | Source: Affitech A/S

Første patient doseret med AT001/r84 i klinisk forsøg i Rusland

København og Oslo, 20. august 2012, 2012-08-20 08:33 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler, at den første patient i det kliniske fase I...
August 20, 2012 02:33 ET | Source: Affitech A/S

First AT001/r84 dose in man in clinical trial in Russia

Copenhagen and Oslo, 20th August, 2012, 2012-08-20 08:33 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that the first patient in the...
August 09, 2012 08:28 ET | Source: Affitech A/S

Affitech receives milestone payment from Roche re. LC06 antibody

Copenhagen and Oslo, 9th August, 2012, 2012-08-09 14:28 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that Roche has reached the first...
August 09, 2012 08:28 ET | Source: Affitech A/S

Affitech modtager milepælsbetaling fra Roche vedrørende LC06 antistof

København og Oslo, 9. august, 2012, 2012-08-09 14:28 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler at Roche har nået den første milepæl i en...